{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T09:07:10Z","timestamp":1774343230380,"version":"3.50.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/tpj.2015.68","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T11:05:06Z","timestamp":1445943906000},"page":"92-97","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Complement 3 and metabolic syndrome induced by clozapine: a cross-sectional study and retrospective cohort analysis"],"prefix":"10.1038","volume":"17","author":[{"given":"C","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"key":"BFtpj201568_CR1","first-page":"943162","volume":"2014","author":"J Kaur","year":"2014","unstructured":"Kaur J . A comprehensive review on metabolic syndrome. Cardiol Res Pract 2014; 2014: 943162.","journal-title":"Cardiol Res Pract"},{"key":"BFtpj201568_CR2","doi-asserted-by":"publisher","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","volume":"97","author":"SM Haffner","year":"2006","unstructured":"Haffner SM . The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006; 97: 3A\u201311A.","journal-title":"Am J Cardiol"},{"key":"BFtpj201568_CR3","first-page":"51","volume":"11","author":"A Sicras-Mainar","year":"2015","unstructured":"Sicras-Mainar A, Maurino J, Ruiz-Beato E, Navarro-Artieda R . Prevalence of metabolic syndrome according to the presence of negative symptoms in patients with schizophrenia. Neuropsychiatr Dis Treat 2015; 11: 51\u201357.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"BFtpj201568_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.schres.2005.07.014","volume":"80","author":"JP McEvoy","year":"2005","unstructured":"McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, Davis SM, Sullivan L et al. Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 2005; 80: 19\u201332.","journal-title":"Schizophr Res"},{"key":"BFtpj201568_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","volume":"70","author":"JM Meyer","year":"2004","unstructured":"Meyer JM, Koro CE . The effects of antipsychotic therapy on serum lipids: a comprehensive review. Schizophr Res 2004; 70: 1\u201317.","journal-title":"Schizophr Res"},{"key":"BFtpj201568_CR6","doi-asserted-by":"publisher","first-page":"S102","DOI":"10.1192\/bjp.184.47.s102","volume":"47","author":"M Peet","year":"2004","unstructured":"Peet M . Diet, diabetes and schizophrenia: review and hypothesis. Br J Psychiatry Suppl 2004; 47: S102\u2013S105.","journal-title":"Br J Psychiatry Suppl"},{"key":"BFtpj201568_CR7","doi-asserted-by":"publisher","first-page":"e72652","DOI":"10.1371\/journal.pone.0072652","volume":"8","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Chen M, Wu Z, Chen J, Yu S, Fang Y et al. Association study of Val66Met polymorphism in brain-derived neurotrophic factor gene with clozapine-induced metabolic syndrome: preliminary results. PLoS One 2013; 8: e72652.","journal-title":"PLoS One"},{"key":"BFtpj201568_CR8","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.schres.2008.01.028","volume":"101","author":"M De Hert","year":"2008","unstructured":"De Hert M, Schreurs V, Sweers K, Van Eyck D, Hanssens L, Sinko S et al. Typical and atypical antipsychotics differentially affect long-term incidence rates of the metabolic syndrome in first-episode patients with schizophrenia: a retrospective chart review. Schizophr Res 2008; 101: 295\u2013303.","journal-title":"Schizophr Res"},{"key":"BFtpj201568_CR9","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/schbul\/sbr148","volume":"39","author":"AJ Mitchell","year":"2013","unstructured":"Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, Yu W, De Hert M . Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders\u2014a systematic review and meta-analysis. Schizophr Bull 2013; 39: 306\u2013318.","journal-title":"Schizophr Bull"},{"key":"BFtpj201568_CR10","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00213-011-2397-y","volume":"219","author":"G Jassim","year":"2012","unstructured":"Jassim G, Skrede S, Vazquez MJ, Wergedal H, Vik-Mo AO, Lunder N et al. Acute effects of orexigenic antipsychotic drugs on lipid and carbohydrate metabolism in rat. Psychopharmacology (Berl) 2012; 219: 783\u2013794.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR11","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1007\/s00213-013-3410-4","volume":"231","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Chen M, Chen J, Wu Z, Yu S, Fang Y et al. Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype. Psychopharmacology (Berl) 2014; 231: 2211\u20132218.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2009.07.031","volume":"314","author":"E Maury","year":"2010","unstructured":"Maury E, Brichard SM . Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol 2010; 314: 1\u201316.","journal-title":"Mol Cell Endocrinol"},{"key":"BFtpj201568_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.mam.2011.10.011","volume":"33","author":"NS Kalupahana","year":"2012","unstructured":"Kalupahana NS, Moustaid-Moussa N, Claycombe KJ . Immunity as a link between obesity and insulin resistance. Mol Aspects Med 2012; 33: 26\u201334.","journal-title":"Mol Aspects Med"},{"key":"BFtpj201568_CR14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/j.1600-0447.1994.tb01527.x","volume":"89","author":"M Maes","year":"1994","unstructured":"Maes M, Meltzer HY, Bosmans E . Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine. Acta Psychiatr Scand 1994; 89: 346\u2013351.","journal-title":"Acta Psychiatr Scand"},{"key":"BFtpj201568_CR15","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/S0920-9964(97)00057-1","volume":"26","author":"M Maes","year":"1997","unstructured":"Maes M, Bosmans E, Kenis G, De Jong R, Smith RS, Meltzer HY . In vivo immunomodulatory effects of clozapine in schizophrenia. Schizophr Res 1997; 26: 221\u2013225.","journal-title":"Schizophr Res"},{"key":"BFtpj201568_CR16","doi-asserted-by":"publisher","first-page":"e59012","DOI":"10.1371\/journal.pone.0059012","volume":"8","author":"V Contreras-Shannon","year":"2013","unstructured":"Contreras-Shannon V, Heart DL, Paredes RM, Navaira E, Catano G, Maffi SK et al. Clozapine-induced mitochondria alterations and inflammation in brain and insulin-responsive cells. PLoS One 2013; 8: e59012.","journal-title":"PLoS One"},{"key":"BFtpj201568_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2005.08.008","volume":"26","author":"EG McGeer","year":"2005","unstructured":"McGeer EG, Klegeris A, McGeer PL . Inflammation, the complement system and the diseases of aging. Neurobiol Aging 2005; 26: 94\u201397.","journal-title":"Neurobiol Aging"},{"key":"BFtpj201568_CR18","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/hq0901.095276","volume":"21","author":"CJ Halkes","year":"2001","unstructured":"Halkes CJ, van Dijk H, de Jaegere PP, Plokker HW, van Der Helm Y, Erkelens DW et al. Postprandial increase of complement component 3 in normolipidemic patients with coronary artery disease: effects of expanded-dose simvastatin. Arterioscler Thromb Vasc Biol 2001; 21: 1526\u20131530.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"BFtpj201568_CR19","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1053\/euhj.1999.2013","volume":"21","author":"A Muscari","year":"2000","unstructured":"Muscari A, Massarelli G, Bastagli L, Poggiopollini G, Tomassetti V, Drago G et al. Relationship of serum C3 to fasting insulin, risk factors and previous ischaemic events in middle-aged men. Eur Heart J 2000; 21: 1081\u20131090.","journal-title":"Eur Heart J"},{"key":"BFtpj201568_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2006.01.009","volume":"190","author":"AJ van Oostrom","year":"2007","unstructured":"van Oostrom AJ, Alipour A, Plokker TW, Sniderman AD, Cabezas MC . The metabolic syndrome in relation to complement component 3 and postprandial lipemia in patients from an outpatient lipid clinic and healthy volunteers. Atherosclerosis 2007; 190: 167\u2013173.","journal-title":"Atherosclerosis"},{"key":"BFtpj201568_CR21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00213-013-3137-2","volume":"230","author":"J Cai","year":"2013","unstructured":"Cai J, Zhang W, Yi Z, Lu W, Wu Z, Chen J et al. Influence of polymorphisms in genes SLC1A1, GRIN2B, and GRIK2 on clozapine-induced obsessive-compulsive symptoms. Psychopharmacology (Berl) 2013; 230: 49\u201355.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.atherosclerosis.2006.10.005","volume":"195","author":"JW Kent Jr","year":"2007","unstructured":"Kent JW Jr, Mahaney MC, Comuzzie AG, Goring HH, Almasy L, Dyer TD et al. Quantitative trait locus on Chromosome 19 for circulating levels of intercellular adhesion molecule-1 in Mexican Americans. Atherosclerosis 2007; 195: 367\u2013373.","journal-title":"Atherosclerosis"},{"key":"BFtpj201568_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/1471-2350-9-103","volume":"9","author":"AT Kraja","year":"2008","unstructured":"Kraja AT, Huang P, Tang W, Hunt SC, North KE, Lewis CE et al. QTLs of factors of the metabolic syndrome and echocardiographic phenotypes: the hypertension genetic epidemiology network study. BMC Med Genet 2008; 9: 103.","journal-title":"BMC Med Genet"},{"key":"BFtpj201568_CR24","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s00125-004-1641-y","volume":"48","author":"P Mackin","year":"2005","unstructured":"Mackin P, Watkinson HM, Young AH . Prevalence of obesity, glucose homeostasis disorders and metabolic syndrome in psychiatric patients taking typical or atypical antipsychotic drugs: a cross-sectional study. Diabetologia 2005; 48: 215\u2013221.","journal-title":"Diabetologia"},{"key":"BFtpj201568_CR25","first-page":"CD006633","volume":"11","author":"C Asenjo Lobos","year":"2010","unstructured":"Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S et al. Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst Rev 2010; 11: CD006633.","journal-title":"Cochrane Database Syst Rev"},{"key":"BFtpj201568_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00213-012-2850-6","volume":"225","author":"JJ Ou","year":"2013","unstructured":"Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J et al. Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia. Psychopharmacology (Berl) 2013; 225: 627\u2013635.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/s00213-006-0384-5","volume":"186","author":"RR Wu","year":"2006","unstructured":"Wu RR, Zhao JP, Liu ZN, Zhai JG, Guo XF, Guo WB et al. Effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Psychopharmacology (Berl) 2006; 186: 572\u2013578.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR28","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00213-011-2555-2","volume":"221","author":"KJ Davey","year":"2012","unstructured":"Davey KJ, O'Mahony SM, Schellekens H, O'Sullivan O, Bienenstock J, Cotter PD et al. Gender-dependent consequences of chronic olanzapine in the rat: effects on body weight, inflammatory, metabolic and microbiota parameters. Psychopharmacology (Berl) 2012; 221: 155\u2013169.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFtpj201568_CR29","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ajmg.b.31242","volume":"156B","author":"S Ryu","year":"2011","unstructured":"Ryu S, Oh S, Cho EY, Nam HJ, Yoo JH, Park T et al. Interaction between genetic variants of DLGAP3 and SLC1A1 affecting the risk of atypical antipsychotics-induced obsessive-compulsive symptoms. Am J Med Genet B Neuropsychiatr Genet 2011; 156B: 949\u2013959.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"BFtpj201568_CR30","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1007\/s12031-010-9458-2","volume":"43","author":"C Zhang","year":"2011","unstructured":"Zhang C, Li ZZ, Shao Y, Xie B, Du YS, Fang YR et al. Association study of tryptophan hydroxylase-2 gene in schizophrenia and its clinical features in Chinese Han population. J Mol Neurosci 2011; 43: 406\u2013411.","journal-title":"J Mol Neurosci"},{"key":"BFtpj201568_CR31","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.diabres.2010.09.001","volume":"90","author":"H Zhou","year":"2010","unstructured":"Zhou H, Guo ZR, Yu LG, Hu XS, Xu BH, Liu HB et al. Evidence on the applicability of the ATPIII, IDF and CDS metabolic syndrome diagnostic criteria to identify CVD and T2DM in the Chinese population from a 6.3-year cohort study in mid-eastern China. Diabetes Res Clin Pract 2010; 90: 319\u2013325.","journal-title":"Diabetes Res Clin Pract"},{"key":"BFtpj201568_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2008.03.001","volume":"201","author":"YQ Bao","year":"2008","unstructured":"Bao YQ, Lu JX, Wang C, Yang M, Li HT, Zhang XY et al. Optimal waist circumference cutoffs for abdominal obesity in Chinese. Atherosclerosis 2008; 201: 378\u2013384.","journal-title":"Atherosclerosis"},{"key":"BFtpj201568_CR33","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/ng.976","volume":"43","author":"S Raychaudhuri","year":"2011","unstructured":"Raychaudhuri S, Iartchouk O, Chin K, Tan PL, Tai AK, Ripke S et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat Genet 2011; 43: 1232\u20131236.","journal-title":"Nat Genet"},{"key":"BFtpj201568_CR34","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1080\/09513590701666571","volume":"23","author":"C Oktenli","year":"2007","unstructured":"Oktenli C, Ozgurtas T, Dede M, Sanisoglu YS, Yenen MC, Yesilova Z et al. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecol Endocrinol 2007; 23: 710\u2013715.","journal-title":"Gynecol Endocrinol"},{"key":"BFtpj201568_CR35","doi-asserted-by":"publisher","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","volume":"112","author":"SM Grundy","year":"2005","unstructured":"Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome - an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005; 112: 2735\u20132752.","journal-title":"Circulation"},{"issue":"5","key":"BFtpj201568_CR36","doi-asserted-by":"publisher","first-page":"2936","DOI":"10.1007\/s12035-015-9193-3","volume":"53","author":"Chen Zhang","year":"2015","unstructured":"Zhang C, Wang Z, Hong W, Wu Z, Peng D, Fang Y . ZNF804A genetic variation confers risk to bipolar disorder. Mol Neurobiol 2015; doi:doi:10.1007\/s12035-015-9193-3.","journal-title":"Molecular Neurobiology"},{"key":"BFtpj201568_CR37","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/rheumatology\/kem321","volume":"47","author":"H Miyagawa","year":"2008","unstructured":"Miyagawa H, Yamai M, Sakaguchi D, Kiyohara C, Tsukamoto H, Kimoto Y et al. Association of polymorphisms in complement component C3 gene with susceptibility to systemic lupus erythematosus. Rheumatology 2008; 47: 158\u2013164.","journal-title":"Rheumatology"},{"key":"BFtpj201568_CR38","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.gene.2015.02.039","volume":"561","author":"QQ Yu","year":"2015","unstructured":"Yu QQ, Yao Y, Zhu J, Bao X, Xie TH, Sun C et al. Nonsynonymous single nucleotide polymorphisms in the complement component 3 gene are associated with risk of age-related macular degeneration: a meta-analysis. Gene 2015; 561: 249\u2013255.","journal-title":"Gene"},{"key":"BFtpj201568_CR39","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.3945\/ajcn.2009.28101","volume":"90","author":"CM Phillips","year":"2009","unstructured":"Phillips CM, Goumidi L, Bertrais S, Ferguson JF, Field MR, Kelly ED et al. Complement component 3 polymorphisms interact with polyunsaturated fatty acids to modulate risk of metabolic syndrome. Am J Clin Nutr 2009; 90: 1665\u20131673.","journal-title":"Am J Clin Nutr"},{"key":"BFtpj201568_CR40","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/gene.2009.23","volume":"10","author":"B Rhodes","year":"2009","unstructured":"Rhodes B, Hunnangkul S, Morris DL, Hsaio LC, Graham DSC, Nitsch D et al. The heritability and genetics of complement C3 expression in UK SLE families. Genes Immun 2009; 10: 525\u2013530.","journal-title":"Genes Immun"},{"key":"BFtpj201568_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/sj.cr.7290286","volume":"15","author":"YY Shi","year":"2005","unstructured":"Shi YY, He L . SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005; 15: 97\u201398.","journal-title":"Cell Res"},{"key":"BFtpj201568_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/jpm5010022","volume":"5","author":"JC Keen","year":"2015","unstructured":"Keen JC, Moore HM . The Genotype-Tissue Expression (GTEx) Project: linking clinical data with molecular analysis to advance personalized medicine. J Pers Med 2015; 5: 22\u201329.","journal-title":"J Pers Med"},{"key":"BFtpj201568_CR43","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1651-2227.2006.00178.x","volume":"96","author":"AK Akobeng","year":"2007","unstructured":"Akobeng AK . Understanding diagnostic tests 3: receiver operating characteristic curves. Acta Paediatr 2007; 96: 644\u2013647.","journal-title":"Acta Paediatr"},{"key":"BFtpj201568_CR44","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1086\/382052","volume":"74","author":"AC Janssens","year":"2004","unstructured":"Janssens AC, Pardo MC, Steyerberg EW, van Duijn CM . Revisiting the clinical validity of multiplex genetic testing in complex diseases. Am J Hum Genet 2004; 74: 585\u2013588.","journal-title":"Am J Hum Genet"},{"key":"BFtpj201568_CR45","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pnpbp.2014.08.015","volume":"56","author":"L Yang","year":"2015","unstructured":"Yang L, Chen JH, Liu DT, Yu SY, Cong EZ, Li Y et al. Association between SREBF2 gene polymorphisms and metabolic syndrome in clozapine-treated patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 2015; 56: 136\u2013141.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"BFtpj201568_CR46","first-page":"1213","volume":"8","author":"X Dong","year":"2015","unstructured":"Dong X, Liao Y, Chen K, Fang Y, Li W, Chen J et al. Elevated red blood cell distribution width in benign prostatic hyperplasia patients with metabolic syndrome. Int J Clin Exp Med 2015; 8: 1213\u20131219.","journal-title":"Int J Clin Exp Med"},{"key":"BFtpj201568_CR47","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/sj.jhh.1002160","volume":"21","author":"SK Nadar","year":"2007","unstructured":"Nadar SK . Lip GYH. New insights into complement C3 and inflammation in hypertension. J Hum Hypertens 2007; 21: 261\u2013263.","journal-title":"J Hum Hypertens"},{"key":"BFtpj201568_CR48","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molimm.2014.06.031","volume":"61","author":"E Hertle","year":"2014","unstructured":"Hertle E, Stehouwer CD, van Greevenbroek MM . The complement system in human cardiometabolic disease. Mol Immunol 2014; 61: 135\u2013148.","journal-title":"Mol Immunol"},{"key":"BFtpj201568_CR49","first-page":"333","volume":"3","author":"X Qin","year":"2006","unstructured":"Qin X, Gao B . The complement system in liver diseases. Cell Mol Immunol 2006; 3: 333\u2013340.","journal-title":"Cell Mol Immunol"},{"key":"BFtpj201568_CR50","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.molimm.2015.02.027","volume":"67","author":"A Barbu","year":"2015","unstructured":"Barbu A, Hamad OA, Lind L, Ekdahl KN, Nilsson B . The role of complement factor C3 in lipid metabolism. Mol Immunol 2015; 67: 101\u2013107.","journal-title":"Mol Immunol"},{"key":"BFtpj201568_CR51","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1053\/j.gastro.2007.01.053","volume":"132","author":"MT Pritchard","year":"2007","unstructured":"Pritchard MT, McMullen MR, Stavitsky AB, Cohen JI, Lin F, Medof ME et al. Differential contributions of C3, C5, and decay-accelerating factor to ethanol-induced fatty liver in mice. Gastroenterology 2007; 132: 1117\u20131126.","journal-title":"Gastroenterology"},{"key":"BFtpj201568_CR52","doi-asserted-by":"publisher","first-page":"S56","DOI":"10.1097\/MPG.0b013e3181a11851","volume":"48","author":"F Backhed","year":"2009","unstructured":"Backhed F . Changes in intestinal microflora in obesity: cause or consequence? J Pediatr Gastroenterol Nutr 2009; 48: S56\u2013S57.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"BFtpj201568_CR53","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1467-789X.2009.00674.x","volume":"11","author":"CS Tam","year":"2010","unstructured":"Tam CS, Clement K, Baur LA, Tordjman J . Obesity and low-grade inflammation: a paediatric perspective. Obes Rev 2010; 11: 118\u2013126.","journal-title":"Obes Rev"},{"key":"BFtpj201568_CR54","doi-asserted-by":"publisher","first-page":"2525","DOI":"10.1007\/s00125-005-0021-6","volume":"48","author":"G Engstrom","year":"2005","unstructured":"Engstrom G, Hedblad B, Janzon L, Lindgarde F . Weight gain in relation to plasma levels of complement factor 3: results from a population-based cohort study. Diabetologia 2005; 48: 2525\u20132531.","journal-title":"Diabetologia"},{"key":"BFtpj201568_CR55","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1210\/endo.141.3.7364","volume":"141","author":"I Murray","year":"2000","unstructured":"Murray I, Havel PJ, Sniderman AD, Cianflone K . Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein. Endocrinology 2000; 141: 1041\u20131049.","journal-title":"Endocrinology"},{"key":"BFtpj201568_CR56","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-1-4614-4118-2_12","volume":"735","author":"C Deltas","year":"2013","unstructured":"Deltas C, Gale D, Cook T, Voskarides K, Athanasiou Y, Pierides A . C3 glomerulonephritis\/CFHR5 nephropathy is an endemic disease in Cyprus: clinical and molecular findings in 21 families. Adv Exp Med Biol 2013; 735: 189\u2013196.","journal-title":"Adv Exp Med Biol"},{"key":"BFtpj201568_CR57","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1097\/01.fpc.0000178311.02878.83","volume":"15","author":"D Wang","year":"2005","unstructured":"Wang D, Johnson AD, Papp AC, Kroetz DL, Sadee W . Multidrug resistance polypeptide 1 (MDR1, ABCB1) variant 3435C>T affects mRNA stability. Pharmacogenet Genomics 2005; 15: 693\u2013704.","journal-title":"Pharmacogenet Genomics"},{"key":"BFtpj201568_CR58","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tig.2006.03.001","volume":"22","author":"R Sladek","year":"2006","unstructured":"Sladek R, Hudson TJ . Elucidating cis- and trans-regulatory variation using genetical genomics. Trends Genet 2006; 22: 245\u2013250.","journal-title":"Trends Genet"},{"key":"BFtpj201568_CR59","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/ar2739","volume":"11","author":"DS Cunninghame Graham","year":"2009","unstructured":"Cunninghame Graham DS . Genome-wide association studies in systemic lupus erythematosus: a perspective. Arthritis Res Ther 2009; 11: 119.","journal-title":"Arthritis Res Ther"},{"key":"BFtpj201568_CR60","doi-asserted-by":"publisher","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","volume":"3","author":"J Vandesompele","year":"2002","unstructured":"Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, De Paepe A et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002; 3: RESEARCH0034.","journal-title":"Genome Biol"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/tpj201568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201568","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/tpj201568.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T11:15:31Z","timestamp":1647947731000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/tpj201568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFtpj201568"],"URL":"https:\/\/doi.org\/10.1038\/tpj.2015.68","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"value":"1470-269X","type":"print"},{"value":"1473-1150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]},"assertion":[{"value":"6 June 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}